LLBO Lifeline Biotech Inc (CE)

Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has completed the updating of the Company’s information on Pinks Sheets.

Jim Holmes, Lifeline’s CEO, said, “The ‘Stop Sign’ on our Company site at Pink Sheets has been removed. The information filed with Pinks Sheets this past week was sufficient to remove the ‘Stop Sign’. The information submitted includes a Balance Sheet, Statement of Operations and Outstanding Common Shares as of June 30, 2009. This information can be seen on Lifeline’s Pink Sheet’s site at www.pinksheets.com. Then enter Lifeline’s trading symbol, LLBO then click on ‘FILINGS’.

“We have had questions on our current FDA filing. We await the FDA’s response, which could be received as early as the end of September. However, that is probably optimistic and it could be some additional 30 to 45 days before we receive the FDA’s response. As soon as we have the response we expect to release the information to the public.

“We’ve also received many questions concerning the prospect of a reverse split of the common stock. We have no plans to reverse split Lifeline’s common stock."

Save Harbor: This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, the ability to obtain financing, successful development of the Company’s product or market acceptance of the product and regulatory and shareholder approval for anticipated actions.

Lifeline Biotech (CE) (USOTC:LLBO)
Historical Stock Chart
From Feb 2025 to Mar 2025

Lifeline Biotech (CE) (USOTC:LLBO)
Historical Stock Chart
From Mar 2024 to Mar 2025